87 related articles for article (PubMed ID: 27323060)
1. Tristetraprolin: a novel mediator of the anticancer properties of resveratrol.
Li C; Tang C; He G
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323060
[TBL] [Abstract][Full Text] [Related]
2. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
[TBL] [Abstract][Full Text] [Related]
3. Tristetraprolin activation by resveratrol inhibits the proliferation and metastasis of colorectal cancer cells.
Lee SR; Jin H; Kim WT; Kim WJ; Kim SZ; Leem SH; Kim SM
Int J Oncol; 2018 Sep; 53(3):1269-1278. PubMed ID: 29956753
[TBL] [Abstract][Full Text] [Related]
4. Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.
Pandiri I; Chen Y; Joe Y; Kim HJ; Park J; Chung HT; Park JW
Breast Cancer Res Treat; 2016 Feb; 156(1):57-64. PubMed ID: 26956973
[TBL] [Abstract][Full Text] [Related]
5. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
6. Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes.
Cao H; Urban JF; Anderson RA
Obesity (Silver Spring); 2008 Jun; 16(6):1208-18. PubMed ID: 18388887
[TBL] [Abstract][Full Text] [Related]
7. Improved antiulcer and anticancer properties of a trans-resveratrol analog in mice.
Guha P; Dey A; Sarkar B; Dhyani MV; Chattopadhyay S; Bandyopadhyay SK
J Pharmacol Exp Ther; 2009 Mar; 328(3):829-38. PubMed ID: 19066340
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells.
Kim YA; Lim SY; Rhee SH; Park KY; Kim CH; Choi BT; Lee SJ; Park YM; Choi YH
Int J Mol Med; 2006 Jun; 17(6):1069-75. PubMed ID: 16685418
[TBL] [Abstract][Full Text] [Related]
9. Orostachys japonicus inhibits the expression of MMP-2 and MMP-9 mRNA and modulates the expression of iNOS and COX-2 genes in human PMA-differentiated THP-1 cells via inhibition of NF-κB and MAPK activation.
Kim YI; Park SW; Yoon YK; Lee KW; Lee JH; Woo HJ; Kim Y
Mol Med Rep; 2015 Jul; 12(1):657-62. PubMed ID: 25760396
[TBL] [Abstract][Full Text] [Related]
10. Function of inducible nitric oxide synthase in the regulation of cervical cancer cell proliferation and the expression of vascular endothelial growth factor.
Dong J; Cheng M; Sun H
Mol Med Rep; 2014 Feb; 9(2):583-9. PubMed ID: 24297386
[TBL] [Abstract][Full Text] [Related]
11. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
12. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
Cao Z; Fang J; Xia C; Shi X; Jiang BH
Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429
[TBL] [Abstract][Full Text] [Related]
13. Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2013 May; 45(5):387-90. PubMed ID: 23225247
[TBL] [Abstract][Full Text] [Related]
14. Post-transcriptional regulation of the human inducible nitric oxide synthase (iNOS) expression by the cytosolic poly(A)-binding protein (PABP).
Casper I; Nowag S; Koch K; Hubrich T; Bollmann F; Henke J; Schmitz K; Kleinert H; Pautz A
Nitric Oxide; 2013 Sep; 33():6-17. PubMed ID: 23711718
[TBL] [Abstract][Full Text] [Related]
15. Anticancer effect of rapamycin on MCF-7 via downregulation of VEGF expression.
Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H
In Vitro Cell Dev Biol Anim; 2016 Jan; 52(1):45-8. PubMed ID: 26427711
[TBL] [Abstract][Full Text] [Related]
16. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.
Du Y; Shi A; Han B; Li S; Wu D; Jia H; Zheng C; Ren L; Fan Z
Int J Oncol; 2014 Apr; 44(4):1385-93. PubMed ID: 24535190
[TBL] [Abstract][Full Text] [Related]
17. Linoleic acid-induced expression of inducible nitric oxide synthase and cyclooxygenase II via p42/44 mitogen-activated protein kinase and nuclear factor-kappaB pathway in retinal pigment epithelial cells.
Fang IM; Yang CH; Yang CM; Chen MS
Exp Eye Res; 2007 Nov; 85(5):667-77. PubMed ID: 17825288
[TBL] [Abstract][Full Text] [Related]
18. Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR.
Linker K; Pautz A; Fechir M; Hubrich T; Greeve J; Kleinert H
Nucleic Acids Res; 2005; 33(15):4813-27. PubMed ID: 16126846
[TBL] [Abstract][Full Text] [Related]
19. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B
Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166
[TBL] [Abstract][Full Text] [Related]
20. Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase.
Korhonen R; Linker K; Pautz A; Förstermann U; Moilanen E; Kleinert H
Mol Pharmacol; 2007 May; 71(5):1427-34. PubMed ID: 17322004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
